<?xml version="1.0" encoding="UTF-8"?>
<!-- generator="wordpress.com" -->
<urlset xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance"
	xsi:schemaLocation="http://www.sitemaps.org/schemas/sitemap/0.9 http://www.sitemaps.org/schemas/sitemap/0.9/sitemap.xsd"
	xmlns="http://www.sitemaps.org/schemas/sitemap/0.9"
	xmlns:news="http://www.google.com/schemas/sitemap-news/0.9"
	xmlns:image="http://www.google.com/schemas/sitemap-image/1.1"
	>
<url><loc>https://gutsandgrowth.com/2026/04/15/food-for-thought-studies-of-food-intake-and-ibs-and-dgbi/</loc><news:news><news:publication><news:name>gutsandgrowth</news:name><news:language>en</news:language></news:publication><news:publication_date>2026-04-15T11:00:00+00:00</news:publication_date><news:title>Food for Thought: Studies of Food Intake and IBS and DGBI</news:title><news:keywords>IBS, FODMAP diet, lactose intolerance, irritable bowel sybdrome, carbohydrate malabsorption</news:keywords></news:news></url><url><loc>https://gutsandgrowth.com/2026/04/14/comparative-safety-of-janus-kinase-inhibitors-vs-tumor-necrosis-factor-antagonists-for-inflammatory-bowel-disease-patients/</loc><news:news><news:publication><news:name>gutsandgrowth</news:name><news:language>en</news:language></news:publication><news:publication_date>2026-04-14T11:01:00+00:00</news:publication_date><news:title>Comparative Safety of Janus Kinase Inhibitors vs Tumor Necrosis Factor Antagonists For Inflammatory Bowel Disease Patients</news:title><news:keywords>Ulcerative colitis, Crohn&#039;s disease, tofacitinib, JAK inhibitor, Upadacitinib, MACE, major cardiovascular events</news:keywords></news:news></url></urlset>
